---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293979012.md"
description: "During Monday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Gossamer Bio (+28.8%), ProMIS Neurosciences (+13.39%), and OPKO Health (+12.9%). Conversely, losers featured Radiopharm Theranostics (-12.6%), Redhill Biopharma (-8.59%), and HeartSciences (-7.91%). These movements followed earnings releases or market reactions."
datetime: "2026-07-27T21:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293979012.md)
  - [en](https://longbridge.com/en/news/293979012.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293979012.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Gossamer Bio** (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million.
-   **ProMIS Neurosciences** (NASDAQ:PMN) shares increased by 13.39% to $13.29. The company's market cap stands at $109.4 million.
-   **OPKO Health** (NASDAQ:OPK) shares increased by 12.9% to $1.4. The company's market cap stands at $921.2 million. As per the press release, Q2 earnings came out today.
-   **OrthoPediatrics** (NASDAQ:KIDS) shares moved upwards by 12.08% to $22.22. The market value of their outstanding shares is at $484.6 million.
-   **Matinas BioPharma Hldgs** (AMEX:MTNB) stock increased by 11.35% to $0.37. The market value of their outstanding shares is at $1.5 million.
-   **Olema Pharmaceuticals** (NASDAQ:OLMA) stock increased by 9.57% to $13.16. The company's market cap stands at $1.0 billion.

### Losers

-   **Radiopharm Theranostics** (NASDAQ:RADX) stock declined by 12.6% to $3.2 during Monday's after-market session. The market value of their outstanding shares is at $27.6 million.
-   **Redhill Biopharma** (NASDAQ:RDHL) stock decreased by 8.59% to $0.64. The company's market cap stands at $3.8 million.
-   **HeartSciences** (NASDAQ:HSCS) shares declined by 7.91% to $2.33. The company's market cap stands at $7.8 million. As per the press release, Q4 earnings came out 2 days ago.
-   **iBio** (NASDAQ:IBIO) shares decreased by 7.58% to $1.34. The market value of their outstanding shares is at $71.0 million.
-   **Cumberland Pharma** (NASDAQ:CPIX) stock decreased by 6.77% to $6.55. The market value of their outstanding shares is at $99.0 million.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) shares decreased by 6.61% to $0.23. The company's market cap stands at $1.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md)
- [OPK.US](https://longbridge.com/en/quote/OPK.US.md)
- [HSCS.US](https://longbridge.com/en/quote/HSCS.US.md)
- [RADX.US](https://longbridge.com/en/quote/RADX.US.md)
- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)
- [PMN.US](https://longbridge.com/en/quote/PMN.US.md)
- [KIDS.US](https://longbridge.com/en/quote/KIDS.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [OLMA.US](https://longbridge.com/en/quote/OLMA.US.md)
- [IBIO.US](https://longbridge.com/en/quote/IBIO.US.md)
- [CPIX.US](https://longbridge.com/en/quote/CPIX.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [HSCSW.US](https://longbridge.com/en/quote/HSCSW.US.md)

## Related News & Research

- [ProMIS Neurosciences to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297649065.md)
- [Gossamer Bio announces $250m in funding to advance seralutinib](https://longbridge.com/en/news/296771347.md)
- [Radiopharm Theranostics doses first patient in second cohort of RV-01 Phase 1/2a trial in B7-H3 solid tumors](https://longbridge.com/en/news/297032752.md)
- [Arcutis Biotherapeutics (NASDAQ:ARQT) Director Terrie Curran Sells 38,200 Shares](https://longbridge.com/en/news/297400113.md)
- [Insider Selling: Gloo (NASDAQ:GLOO) Major Shareholder Sells 4,000 Shares](https://longbridge.com/en/news/297377530.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**